April 2024
Preliminary Pricing Supplement No. 1,619
Registration Statement Nos. 333-275587; 333-275587-01
Dated March 29, 2024
Filed pursuant to Rule 424(b)(2)
Morgan Stanley Finance LLC
Structured Investments
Opportunities in U.S. Equities
Jump Securities with Auto-Callable... (continue reading...)
For the monthly distribution period from: February 17, 2024 to March 15, 2024
Commission File Number of issuing entity: 333-255934-03
Central Index Key Number of issuing entity: 0001942599
BMO 2022-C3 Mortgage Trust(Exact name of issuing entity as specified in... (continue reading...)
JPMorgan Chase Financial Company LLC Structured Investments
$4,409,000
Auto Callable Contingent Interest Notes Linked to the Class A Subordinate Voting Shares of Shopify Inc. due April 1, 2026
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
·The notes are designed for investors who seek a Contingent Interest Payment with respect to each... (continue reading...)More SEC Filings
View Older Stories-
Form D CLT IC IV, LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 10-D BMO 2022-C1 Mortgage For: Mar 15
-
Form 10-K Altisource Asset Managem For: Dec 31
-
Form NT 10-K Authentic Holdings, Inc. For: Dec 31
-
Form ABS-EE BMO 2022-C3 Mortgage For: Mar 15
-
Form D Ecofashion Corp P.B.C.
-
Form ABS-EE BMO 2022-C1 Mortgage For: Mar 15
-
Form 424B2 MORGAN STANLEY
-
Form PRE 14A BLACKBAUD INC For: Dec 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form DEFR14A LAS VEGAS SANDS CORP
-
Form NT 10-K SILVER STAR PROPERTIES For: Dec 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 TORONTO DOMINION BANK
-
Form 10-D Benchmark 2023-V4 Mortga For: Mar 15
-
Form MA/A Sustainable Capital Advi
-
Form 8-K Elicio Therapeutics, For: Mar 29
-
Form 8-K CalciMedica, Inc. For: Mar 29
-
Form ABS-EE Benchmark 2023-V4 Mortga For: Mar 15
-
Form 424B2 MORGAN STANLEY
-
Form ARS ALKAMI TECHNOLOGY, INC. For: Mar 29
-
Form MA-A DiPerna & Company, LLC For: Dec 31
-
Form 10-D Benchmark 2023-B39 Mortg For: Mar 15
-
Form 424B5 CalciMedica, Inc.
-
Form DEFA14A ALKAMI TECHNOLOGY, INC.
-
Form N-8A Pop Venture Fund
-
Form 6-K Evaxion Biotech A/S For: Mar 29
-
Form 424B2 MORGAN STANLEY
-
Form DEF 14A ALKAMI TECHNOLOGY, INC. For: Dec 31
-
Form 15-15D Opti-Harvest, Inc.
-
Form NT 10-K Bannix Acquisition Corp. For: Dec 31
-
Form ABS-EE Benchmark 2023-B39 Mortg For: Mar 15
-
Form 8-K Gannett Co., Inc. For: Mar 29
-
Form 6-K ROYAL BANK OF CANADA For: Mar 29
-
Form 10-K Enservco Corp For: Dec 31
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 MORGAN STANLEY
-
Form 8-K Sphere 3D Corp. For: Mar 18
-
Form 10-D Citigroup Commercial For: Mar 15
-
Form MA-A David Taussig & Associat For: Dec 31
-
Form D/A Assurified, Inc.
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: RAJKOWSKI E MARK
-
Form ABS-EE Citigroup Commercial For: Mar 15
-
Form 424B2 MORGAN STANLEY
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Monteagudo Graciela
-
Form S-8 KALA BIO, Inc.
-
Form PRE 14A Merus N.V. For: May 07
-
Form D Synergist Technology,
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Lombardi Ronald M.